Medicine and Dentistry
Randomized Controlled Trial
100%
Adverse Event
30%
Health Care Cost
28%
Cost-Effectiveness Analysis
26%
Lung
25%
Quality of Life
22%
Cystic Fibrosis
22%
Lung Clearance
22%
Patient Health Questionnaire 15
19%
Quality Adjusted Life Year
17%
Physical Activity
17%
Primary Health Care
14%
National Health Service
13%
Medically Unexplained Physical Symptoms
12%
Chest Physiotherapy
12%
Lung Cancer Screening
12%
Chronic Pain
11%
Asthma
11%
Cardiovascular Risk
11%
Weight Management
11%
Malignant Neoplasm
11%
Nitric Oxide
11%
Breast Screening
11%
Lifestyle Intervention
11%
COVID-19
11%
Breast Cancer Screening
11%
Computer Assisted Tomography
11%
Biological Marker
11%
Low Drug Dose
11%
Atrial Fibrillation
11%
Breast Cancer
11%
Neurosurgery
11%
Premature Labor
11%
Stereotactic Radiosurgery
11%
Intensive Care
11%
Twin Pregnancy
11%
Pelvis Pain Syndrome
11%
Cervix
11%
Pessary
11%
Cavernoma
11%
Melanoma
11%
Bath Ankylosing Spondylitis Functional Index
11%
Patient Referral
11%
Case Finding
11%
Electrocardiogram
9%
Behavioral Change
7%
Body Mass Index
7%
Health Care
7%
Intervention Trial
7%
Masking
7%
Nursing and Health Professions
General Practitioner
57%
Adverse Event
30%
Quality Adjusted Life Year
24%
Cystic Fibrosis
22%
Lung Clearance
22%
Cost Effectiveness Analysis
20%
Quality of Life
19%
Patient Health Questionnaire 15
19%
Randomization
14%
Medically Unexplained Symptom
13%
Health Care
12%
Breathing Exercise
12%
Chronic Pain
11%
Socialized Medicine
11%
Vagina Pessary
11%
Breast Cancer
11%
Twin Pregnancy
11%
Primary Medical Care
11%
Pandemic
11%
Patient Referral
11%
Pelvis Pain Syndrome
11%
Premature Labor
11%
Sample Size
7%
General Practice
7%
Intention to Treat Analysis
7%
Incremental Cost-Effectiveness Ratio
7%
Masking
7%
Health Economics
6%
Coughing
6%
Tezacaftor
6%
Ivacaftor
6%
Physical Disease
5%
Weight Management
5%
Cancer Screening
5%
Content Analysis
5%
Care Group
5%
